Govt orders study to gauge hurdles in producing APIs
1 year, 3 months ago

Govt orders study to gauge hurdles in producing APIs

Live Mint  

NEW DELHI : In order to strengthen the domestic production of Active Pharmaceuticals Ingredients, the Department of Pharmaceuticals is conducting a first-of-its-kind study on the gaps and challenges in the sector. In this regard, all pharma companies and drug manufacturing associations have been asked to share the import and export data of APIs for analyzing the domestic industry, financial gaps and technological challenges to make India future-ready in the global market. “The study aims to map the domestic API industry to capture necessary data in different states for import and consumption, domestic and export sales including the production in the last five years. Meanwhile, India has started production of 22 APIs or bulk drugs used for manufacturing life-saving drugs along with high-end medical devices like CT scans and MRI machines, under the Production Linked Incentive scheme. In order to make the country self-reliant in APIs and drug intermediates, the Central government is implementing various schemes by attracting large investments in the sector to ensure their sustainable domestic supply.

India Drug Apis Bulk Drugs  various  hurdles  apis  financial  bulk  gauge  production  orders  govt  india  drug  domestic  drugs  study  industry  producing

History of this topic

More M. Tech seats in medical engineering to be created; trade gap in medical devices to be wiped out in five years
4 weeks ago

More M. Tech seats in medical engineering to be created; trade gap in medical devices to be wiped out in five years

Live Mint  

New Delhi: The government will start M. Tech courses in medical engineering at leading institutions like IITs and NITs among measures aimed at creating a pool of skilled talent for testing and operating high-tech medical devices and reducing import dependence in this key sector. Other measures include scaling up the number of seats for this course in National Institutes for …

Bulk drug makers to benefit from price stability but need to improve efficiency to compete with Chinese rivals: Experts
1 month ago

Bulk drug makers to benefit from price stability but need to improve efficiency to compete with Chinese rivals: Experts

Live Mint  

Mumbai: Softening prices of active pharmaceutical ingredients are likely to stabilise in the months ahead and bring relief to Indian manufacturers, but they will still have to improve their operational efficiency to compete against Chinese rivals, industry executives and analysts said. API prices have been falling for the past 12-15 months, driven mainly by sharp price cuts by Chinese companies, …

How is India streamlining the pharma sector? | Explained
7 months, 1 week ago

How is India streamlining the pharma sector? | Explained

The Hindu  

The story so far: India’s drug regulator, the Central Drugs Standard Control Organisation, has withdrawn powers delegated to State licensing authorities to issue NOCs for manufacture of unapproved, banned or new drugs for export purposes. This latest announcement covering drugs for export comes at a time when India has been under scrutiny for allegations of supplying substandard drugs causing health …

India’s import of Active Pharmaceutical Ingredients and Key Starting Material from other countries including China grew: Ministry
1 year ago

India’s import of Active Pharmaceutical Ingredients and Key Starting Material from other countries including China grew: Ministry

The Hindu  

December 09, 2023 03:57 pm | Updated 03:57 pm IST - NEW DELHI The quantity and the value of bulk drug and drug intermediates imported from other countries including China during the last two years has only grown in the last financial year according to information given by the Ministry of Chemicals and Fertilizers to the Parliament this week. Responding …

India pharma industry to reach $130 billion by 2030
1 year ago

India pharma industry to reach $130 billion by 2030

The Hindu  

The Indian pharmaceutical industry is expected to reach $130 billion mark by 2030 said a top industry executive at the CPHI & PMEC India expo. This growth is propelled by expanding market opportunities, heightened demand in the USA, and critical shortages of medicines in the U.S. and Europe,” said Dr. Veeramani S.V., Chairman, Pharmaceuticals Export Promotion Council of India. Anil …

Pharma Star: India Steering Global Supply Chain Away from China - News18
1 year ago

Pharma Star: India Steering Global Supply Chain Away from China - News18

News 18  

India’s pharmaceutical industry is at a pivotal juncture. With its well-established prowess in generic drug manufacturing, it has been called on by the world to build a reliable base for the manufacture of raw materials, which offers an opportunity for India to attract the bulk of the pharmaceutical supply chains away from China. “India has started producing 45 APIs after …

Mega schemes for pharma development, med-tech innovation and reducing dependency API import to be announced next month
1 year, 3 months ago

Mega schemes for pharma development, med-tech innovation and reducing dependency API import to be announced next month

The Hindu  

The Ministry of Chemicals and Fertilizers will soon announce a ₹5,000-crore research programme aimed at reducing India’s import dependency on Active Pharmaceutical Ingredients and promoting discovery of new drug molecules. “The policies aim to engage nine established pharmaceutical companies in impact research across six priority areas with prestigious government institutes. It also approved a new Scheme for Promotion of Research …

Indian pharma industry to hit $57 billion by FY25
1 year, 5 months ago

Indian pharma industry to hit $57 billion by FY25

Live Mint  

New Delhi: Domestic pharmaceutical industry will likely hit $57 billion by FY25, along with expansion in operating margins by 100-150 basis points, according to a report by CareEdge Ratings. During FY18 to FY23, the Indian pharmaceutical industry has logged a a compound annual growth rate of 6-8%, primarily driven by an 8% increase in exports and a 6% rise in …

Pharma City To See Rs 20k Cr Investments From Bulk Drug Players: BDMA National Prez
1 year, 6 months ago

Pharma City To See Rs 20k Cr Investments From Bulk Drug Players: BDMA National Prez

Deccan Chronicle  

HYDERABAD: Telangana is likely to see an investment of about Rs 20,000 crore from local bulk drug players once Pharma City is ready, said R.K. Agrawal, president of the industry body Bulk Drug Manufacturers Association. This number is set to increase significantly as more players will look to set up facilities after the Pharma City, the largest pharma manufacturing cluster …

Indian Bulk Drugs Industry Poised For Growth: Jayesh
1 year, 6 months ago

Indian Bulk Drugs Industry Poised For Growth: Jayesh

Deccan Chronicle  

HYDERABAD: The bulk drugs industry is at the cusp of an evolution with start-ups and technology players getting into the value chain. Focus should also be on the environment, social issues, and governance as in the days to come the buyer countries will insist on the processes adopted in the manufacturing and packaging of drugs, said principal secretary Jayesh Ranjan. …

India's Pharma Sector In 2023 And Beyond: Shaping New Paradigm With Innovation And Easier Regulatory Processes
1 year, 7 months ago

India's Pharma Sector In 2023 And Beyond: Shaping New Paradigm With Innovation And Easier Regulatory Processes

News 18  

Recently, Union Health Minister, Mansukh Mandaviya highlighted that research and innovation are necessary for the sustained growth of the pharmaceuticals sector. In line with this, the government has initiated various steps such as pharma innovation, new programme to promote research and innovation in pharmaceuticals is being taken up through Centres of Excellences While India’s pharma industry has progressed by leaps …

Budget 2023: An Opportunity To Push India's Pharma Industry Development
1 year, 10 months ago

Budget 2023: An Opportunity To Push India's Pharma Industry Development

News 18  

The Union Budget 2023-24 will be presented on February 1 against the backdrop of a global recessionary fear. Several public sector schemes launched in the past few years, including the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission, have focused on building last-mile infrastructure. Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance Secretary General Sudarshan …

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?
1 year, 10 months ago

Union Budget 2023-24: Will Budget provide a booster dose for Indian pharmaceutical industry?

Firstpost  

The Indian pharmaceuticals industry showed resilience, speed, and reliability in dealing with the COVID-19 pandemic challenges in India and provided much-needed aid to many other countries. With rising inflation in many countries and the recent surge in COVID-19 cases in China, the Indian pharmaceuticals industry is awaiting strong policy measures to provide further impetus to continue the ‘Make in India’ …

India@75: Phenomenal journey of the pharma industry
2 years, 1 month ago

India@75: Phenomenal journey of the pharma industry

Hindustan Times  

The Indian pharmaceutical industry has come a long way since the country’s independence. Among private players, Khwaja Abdul Hamied had already set up one of India’s oldest pharma companies, Cipla in 1935; Indravan Modi set up Cadila pharmaceuticals in the early 1950s, Kallam Anji Reddy set up Dr Reddy’s Laboratories in Hyderabad and Bhai Parvinder Singh set up Ranbaxy in …

India Plans to Revive Dormant API Manufacturing Industry, Cut Over Dependence on China
3 years, 5 months ago

India Plans to Revive Dormant API Manufacturing Industry, Cut Over Dependence on China

News 18  

The Indian pharmaceutical industry is one of the major contributors to the Indian economy and it is the world’s third-largest industry by volume. As the world’s top supplier of bulk drugs and formulations, Indian pharmaceutical plants consistently attract the highest number of FDA approvals outside of the US, and the country submits more than 40 per cent of all global …

Indian Pharma Firms Go Local Seeking to End Reliance on China
3 years, 10 months ago

Indian Pharma Firms Go Local Seeking to End Reliance on China

News 18  

Indian drug companies are looking to local makers of so-called active pharmaceutical ingredients or trying to make them in-house in a bid to end their reliance on China as ties between the two countries soured after a deadly border clash last June. Disruption to supplies from China due to the COVID-19 pandemic was also a major factor, they said, as …

Atmanirbhar Bharat: Govt approves ₹15,000 cr to pharma sector to boost local drug production
4 years, 1 month ago

Atmanirbhar Bharat: Govt approves ₹15,000 cr to pharma sector to boost local drug production

Live Mint  

The Cabinet on Wednesday announced production linked incentives for 10 sectors including auto, pharmaceuticals and textiles worth ₹2 lakh crore in a bid to boost manufacturing, make India self reliant and generate employment. Briefing reporters after a meeting of the Cabinet, Information and Broadcasting Minister Prakash Javadekar said production-linked incentives will be offered for sectors such as white goods manufacturing, …

Can India still be ’pharmacy of the world’ while reducing import dependence of APIs?
4 years, 3 months ago

Can India still be ’pharmacy of the world’ while reducing import dependence of APIs?

Live Mint  

New Delhi: After Covid-19 pandemic, India's focus to reduce import dependence of Active Pharmaceutical Ingredients and key starting material for drug manufacturing might just affect the country's position as the 'pharmacy of the world'. However, self-reliance has also been necessitated due to the sharp rise in prices of APIs sourced from China in recent years,” said Gurpreet Sandhu, President, Council …

Govt Has Taken Several Measures to Reduce Dependence on Import of Medical Devices: Gowda
4 years, 4 months ago

Govt Has Taken Several Measures to Reduce Dependence on Import of Medical Devices: Gowda

News 18  

The government has taken several measures to reduce the country's dependence on import of medical devices and for the development of domestic capacity in the sector, Minister of Chemicals and Fertilisers D V Sadananda Gowda said on Thursday. However, India is heavily dependent on imports in case of finished medical devices as well as for critical medical device components, Gowda …

Govt to Boost Drug and Medical Device Production to Lessen Reliance on Imports amid Tiff with China
4 years, 4 months ago

Govt to Boost Drug and Medical Device Production to Lessen Reliance on Imports amid Tiff with China

News 18  

The government on Monday released guidelines of four schemes for the development of bulk drug and medical device parks across the country to promote their domestic manufacturing. "In line with the vision of Prime Minister Narendra Modi, the schemes have been conceptualised for making India Atma Nirbhar in pharma sector," Union Minister of Chemicals and Fertilisers DV Sadananda Gowda said …

Govt releases guidelines for schemes to boost domestic manufacturing of bulk drugs, med devices
4 years, 4 months ago

Govt releases guidelines for schemes to boost domestic manufacturing of bulk drugs, med devices

India TV News  

The government on Monday released guidelines of four schemes for the development of bulk drug and medical device parks in the country to promote their domestic manufacturing. "In line with the vision of Prime Minister Shri Narendra Modi, the schemes have been conceptualised for making India ''Atma Nirbhar'' in the pharma sector," Union Minister of Chemicals and Fertilisers D V …

Discover Related